The PERT Consortium/X
Aug 15, 2025, 23:24
PERT 2025 Symposium Session XIII: Expert Insights on CTEPH Diagnosis, Surgery and BPA Innovations – Join the Conversation
The PERT Consortium posted on X:
”PERT 2025 Symposium Spotlight: SESSION XIII – CTEPH (Chronic Thromboembolic Pulmonary Hypertension)
Moderators: Drs. Belinda Rivera-Lebron and Timothy Fernandes
When pulmonary embolism doesn’t resolve, chronic complications demand nuanced care. This session dives deep into how acute PE evolves—and what to do when it does.
Highlights include:
- How and Why Does the Acute Become Chronic – Dr. Timothy Morris explores the transition from PE to chronic disease.
- Making the Diagnosis – Dr. Josanna Rodriguez-Lopez decodes the nuances between CTEPH, CTED, CTEVI, and CTESSA.
- PTE (Pulmonary Thromboendarterectomy) – Dr. Michael Madani walks through the gold-standard surgical approach.
- BPA (Balloon Pulmonary Angioplasty) – Dr. Rich Krasuski shares how BPA is changing the treatment landscape.
Followed by expert Q and A with panelists Drs. William Auger, Rich Krasuski, Michael Madani, Josanna Rodriguez-Lopez, Richard Shemin, and Alison Witkin.
Don’t miss your chance to join the conversation at PERT 2025.”
Stay updated with Haemostasis Today.
-
Oct 13, 2025, 03:53Ganesh Mohan is Organising a Webinar to Improve Awareness About Thrombophilia on World Thrombosis Day
-
Oct 13, 2025, 02:47Thomas Reiser: Don't Miss This ISTH Research Recap with Robert Sidonio, Cedric Hermans and Michael Makris
-
Oct 12, 2025, 15:39Renjith Vijayakumar Selvarani: A Heart Attack Isn’t Just a Health Scare — It’s a Medical Emergency
-
Oct 12, 2025, 11:28Is it time for GLP1 receptor agonists in VTE care?
-
Oct 12, 2025, 11:26WFH: Women and Girls with Bleeding Disorders
-
Oct 13, 2025, 03:32Wolfgang Miesbach: This Study from Children's Hospital of Philadelphia Provides Crucial Insights Into Elevidys
-
Oct 13, 2025, 02:43Lukas Meyer and Colleagues on Reperfusion-dependent Treatment Effects of Thrombectomy in Large Ischemic Infarcts
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 12, 2025, 07:28Roberta Gualtierotti: rFVIIIFc and rFIXFc Ensured Effective Haemostasis and Favourable Safety in Major Orthopaedic Surgery
-
Oct 12, 2025, 01:32Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 13, 2025, 03:44Jorge Monge: It Was An Honor to Take Part in the 3rd EBA Workshop on Rare Blood Provision
-
Oct 13, 2025, 03:15Arun V. J: They Chose Death Over A Blood Transfusion — And Here’s Why I Stopped Judging Them
-
Oct 13, 2025, 03:13Rahaf Ajaj: The Persistent Gender Gap in Nobel Prizes - A Call for Greater Inclusion
-
Oct 13, 2025, 02:50Emmanuel J Favaloro: Again Promoting World Thrombosis Day - October 13
-
Oct 12, 2025, 07:38Antonio Vega With Incredible Team Led by the Great Dr Majluf
Oct 13, 2025, 02:50
Oct 12, 2025, 11:28